- About us
- Regulatory Affairs
- Pharmacovigilance & Med. Affairs
- Quality & Manufacturing (GMP)
- Business Development
Under responsibility of our QPPVs, we
Periodic Safety Update Reports (PSURs)
represent a written evaluation of the benefits and risks of a medicinal product and shall be submitted by the marketing authorisation holder at certain time points during the post-authorisation phase. The frequency with which PSURs shall be submitted for a particular product is defined by European and national regulations, taking into account the product type and the amount of clinical evidence and experience available for the concerned active substance.